Associate Director, Economic Modeling

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.  We provide an inclusive work environment where each person is considered as an individual.  At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Market Access

Job Sub Function:

Health Economics Outcomes Research

Job Category:

Professional

All Job Posting Locations:

Titusville, New Jersey, United States of America

Job Description:

Associate Director, Economic Modeling

About Innovative Medicine

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow.

Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way.

Learn more at https://www.jnj.com/innovative-medicine

We are searching for the best talent for an Associate Director, Economic Modeling to be located in Titusville, NJ.

Purpose: Seeking to enhance our economic modeling capability.  In this capacity the Associate Director, Economic Modeling, will design and deliver rigorous economic modelling analytics that address business questions, and will champion best in class modeling methodology within Scientific Evidence & Policy Research (SEPR) at Scientific Affairs.

The Associate Director will be an integral part of the Real World Analytics and Research teams and will closely work with stakeholders within Scientific Affairs, Medical Affairs, New Products & Business Development (NPBD), Strategic Customer Group, Global Health Economic Modeling, and other functions to perform scientifically rigorous modelling analytics. This person will design, lead, and execute economic modelling plans and ensure high-level technical, scientific, and methodological expertise. The successful candidate will apply computational methods for economic modelling and predictive analytics, and establish and maintain modelling standards of excellence that are intended for novel economic model development and communication.

Activities may also include:  leading the J&J Innovative Medicine US, Scientific Affairs’ economic modeling strategy to evolve the assessment of outcomes across therapeutic area (TA) in Innovative Medicines; horizon scanning key developments in economic modeling methodology and international/ national standards and bringing this insight into J&J Innovative Medicine US, Scientific Affairs; early modeling for strategic input to development design and strategy; input to global core models; and local model adaptations and budget impact tools.

You will be responsible for:

• Develop best in class innovative modeling methodology (parametric and/or non-parametric economic modelling techniques) that ensures optimal access for J&J Innovative Medicine US portfolio.
• Align on the J&J Innovative Medicine US external strategy to evolve payer methodology in the assessment of the value of J&J Innovative Medicines US portfolio.
• Serve as the modeling SME to strengthen our proposition and capabilities in NA for economic model development, with strong in-house expertise in economic modeling.
• Engage early with product development by supporting clinical trial designs in the US market, which includes guiding go/no-go decision-making for early pipeline products, right patient population and right comparator(s), also to collaborate with Global Health Economics to create US models or adapt models tailored to specific population of interest in the US.
• Horizon scan latest advances in modeling methodology from academia, payers and competitors embedding key learnings.
• Assess urgent mod